Nuventra Pharma Sciences is now Allucent. Learn more here.

Take a deeper dive

Webinar | Intro to PBPK & QSP: Modeling Approaches for All Stages of Drug Development

This webinar covers an introduction to PBPK and QSP modeling, including a brief explanation of each approach while also diving deeper into how they can be applied across all stages of drug development. The webinar will also touch upon the advantages of integrating these approaches early in your drug development pipeline.

At the end of this webinar, attendees should have a better understanding of:

  • The core principles behind PBPK and QSP modeling
  • How data collected through standard drug development can be better prioritized by incorporating these modeling tools early in the process
  • Where PBPK and QSP modeling can be applied for drugs currently in various stages of the development pipeline

Meet the Presenter

Salil N. Pendse, M.S.
Quantitative Systems Pharmacologist II

Salil has more than 7 years of experience building mathematical models of cellular modes of action, physiologically-based pharmacokinetic (PBPK) modeling, bioinformatics, and building visualization tools for effective communication of complex scientific results. He has authored or co-authored more than 20 peer-reviewed publications in toxicology ranging from novel algorithms for interpreting transcriptomics data, to using PBPK modeling for informing chemical safety in juvenile populations.

Explore Our Blog

Compartmental Modeling in Pharmacokinetics

Pharmacokinetic (PK) modeling is a tool used to help drug developers understand a drug’s effects on the body by analyzing…

Read More

Determining First-in-Human (FIH) Dose for Clinical Studies

First-in-Human (FIH) studies are designed and conducted based on nonclinical data submitted to and reviewed by regulatory authorities. For the…

Read More

How to Use Modeling and Simulation to Optimize a 505(b)(2) Application

A 505(b)(2) application is a hybrid of a full new drug application and an abbreviated new drug application. The terms…

Read More